Corcept Therapeutics
CORT
80 hedge funds and large institutions have $244M invested in Corcept Therapeutics in 2015 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 37 increasing their positions, 16 reducing their positions, and 6 closing their positions.
27,467% more call options, than puts
Call options by funds: $2.48M | Put options by funds: $9K
267% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 6
131% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 16
25% more funds holding
Funds holding: 64 → 80 (+16)
14% more capital invested
Capital invested by funds: $215M → $244M (+$29.8M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$2.74M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.32M |
| 3 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$1.85M |
| 4 |
ISL
Ingalls & Snyder LLC
New York
|
+$1.69M |
| 5 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
+$1.49M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IA
Investor AB
Stockholm,
Sweden
|
-$8.23M |
| 2 |
State Street
Boston,
Massachusetts
|
-$920K |
| 3 |
Invesco
Atlanta,
Georgia
|
-$241K |
| 4 |
SIM
Spark Investment Management
New York
|
-$240K |
| 5 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$237K |
CORT Hedge Fund Activity: Q2 2015 in Review
80 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Corcept Therapeutics (CORT) for Q2 2015, worth a combined $244M — up 14% from $215M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new CORT positions and 6 closed out — a net gain of 16 holders — while 37 added to existing stakes and 16 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $2.74M. The largest seller was Investor AB, cutting an estimated $8.23M.
- 80 institutional investors held Corcept Therapeutics (CORT) as of Q2 2015, up from 64 in Q1 2015.
- Funds reported $244M of Corcept Therapeutics stock for Q2 2015, up 14% quarter-over-quarter.
- 22 funds opened new Corcept Therapeutics positions in Q2 2015 and 6 closed out, a net change of +16 holders.
- The largest Corcept Therapeutics buyer in Q2 2015 was Renaissance Technologies, an estimated $2.74M added.
- The largest Corcept Therapeutics seller in Q2 2015 was Investor AB, an estimated $8.23M sold.
Based on aggregated 13F filings for Q2 2015.